In Canada, switching to a one-dose, gender-neutral vaccination program for human papillomavirus (HPV) could use vaccine doses more efficiently and prevent a similar number of cervical cancer cases, ...

A highly promising vaccine for Hanta virus is being developed by researchers from the University of Bath. The team is led ...

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help ...

COPENHAGEN, Denmark — The United States, a nation of 343 million people with a complex and overburdened health care system, is poised to adopt the childhood vaccine recommendations used in Denmark, a ...

Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...

Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...

NASHVILLE Tenn. (WKRN) — It can take more than a decade to develop a new vaccine for children. After years of research and testing, some don’t pass the safety checks. One laboratory at Vanderbilt ...

A vaccine first developed to protect koalas from a devastating disease is now offering rare insights that could help accelerate human vaccine development for one of the world's most common sexually ...

Delayed hepatitis B vaccination in infants whose birth parents tested negative for HBsAg is associated with adverse health outcomes.